Stem Cell Research (Dec 2022)

Generation of the human pluripotent stem cell lines KUMi005-A from a patients with multiple myeloma

  • Ji-Hea Kim,
  • Ji-Hyeon Hong,
  • Ka-Won Kang,
  • Byung-Hyun Lee,
  • Young Park,
  • Byung-Soo Kim

Journal volume & issue
Vol. 65
p. 102939

Abstract

Read online

Multiple myeloma (MM) progresses with abnormal monoclonal proliferation and accumulation of malignant plasma cells in the bone marrow. We established human induced pluripotent stem cells (iPSCs), KUMi005-A, from bone marrow samples of a patient with MM. This reprogrammed cell line has similar characteristics to human embryonic stem cells, such as proliferation properties and pluripotency. KUMi005-A iPSCs may be applicable in MM disease modeling and cell-based therapies.